Therapeutic Nuclear Medicines Market to Raise at a CAGR of over 11.1% from 2018 to 2028 : Lantheus Medical Imaging, Inc., Eckert & Ziegler and International Isotopes Inc
Increasing acceptance of therapeutic nuclear medicines (or radiopharmaceuticals) among industry experts will remain a prominent factor encouraging their adoption. Though associated with a negligible risk factor, radiopharmaceuticals are likely to witness growing recommendation owing to no proven significant adverse effects.
View full press release